BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12087055)

  • 1. Characterization of aquaporin-4 in muscle and muscular dystrophy.
    Crosbie RH; Dovico SA; Flanagan JD; Chamberlain JS; Ownby CL; Campbell KP
    FASEB J; 2002 Jul; 16(9):943-9. PubMed ID: 12087055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aquaporins in skeletal muscle: reassessment of the functional role of aquaporin-4.
    Frigeri A; Nicchia GP; Balena R; Nico B; Svelto M
    FASEB J; 2004 May; 18(7):905-7. PubMed ID: 15033928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of sarcolemma nNOS in sarcoglycan-deficient muscle.
    Crosbie RH; Barresi R; Campbell KP
    FASEB J; 2002 Nov; 16(13):1786-91. PubMed ID: 12409321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aquaporin-4 deficiency in skeletal muscle and brain of dystrophic mdx mice.
    Frigeri A; Nicchia GP; Nico B; Quondamatteo F; Herken R; Roncali L; Svelto M
    FASEB J; 2001 Jan; 15(1):90-98. PubMed ID: 11149896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered aquaporin-4 expression in human muscular dystrophies: a common feature?
    Frigeri A; Nicchia GP; Repetto S; Bado M; Minetti C; Svelto M
    FASEB J; 2002 Jul; 16(9):1120-2. PubMed ID: 12039847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in skeletal muscle expression of AQP1 and AQP4 in dystrophinopathy and dysferlinopathy patients.
    Au CG; Butler TL; Egan JR; Cooper ST; Lo HP; Compton AG; North KN; Winlaw DS
    Acta Neuropathol; 2008 Sep; 116(3):235-46. PubMed ID: 18392839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disrupted mechanical stability of the dystrophin-glycoprotein complex causes severe muscular dystrophy in sarcospan transgenic mice.
    Peter AK; Miller G; Crosbie RH
    J Cell Sci; 2007 Mar; 120(Pt 6):996-1008. PubMed ID: 17311848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the Role of Aquaporin 4 in Skeletal Muscle Function.
    Aslesh T; Al-Aghbari A; Yokota T
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of mdx mice.
    Vajda Z; Pedersen M; Doczi T; Sulyok E; Nielsen S
    Neuroscience; 2004; 129(4):993-8. PubMed ID: 15561414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption.
    Straub V; Rafael JA; Chamberlain JS; Campbell KP
    J Cell Biol; 1997 Oct; 139(2):375-85. PubMed ID: 9334342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcoglycans in muscular dystrophy.
    Hack AA; Groh ME; McNally EM
    Microsc Res Tech; 2000 Feb 1-15; 48(3-4):167-80. PubMed ID: 10679964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor-regulated channel.
    Iwata Y; Katanosaka Y; Arai Y; Komamura K; Miyatake K; Shigekawa M
    J Cell Biol; 2003 Jun; 161(5):957-67. PubMed ID: 12796481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential targeting of nNOS and AQP4 to dystrophin-deficient sarcolemma by membrane-directed alpha-dystrobrevin.
    Adams ME; Tesch Y; Percival JM; Albrecht DE; Conhaim JI; Anderson K; Froehner SC
    J Cell Sci; 2008 Jan; 121(Pt 1):48-54. PubMed ID: 18057022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiomyopathy is independent of skeletal muscle disease in muscular dystrophy.
    Zhu X; Wheeler MT; Hadhazy M; Lam MY; McNally EM
    FASEB J; 2002 Jul; 16(9):1096-8. PubMed ID: 12039854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syntrophin-dependent expression and localization of Aquaporin-4 water channel protein.
    Neely JD; Amiry-Moghaddam M; Ottersen OP; Froehner SC; Agre P; Adams ME
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):14108-13. PubMed ID: 11717465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
    Tidball JG; Wehling-Henricks M
    Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aquaporin 4 mRNA levels in neuromuscular tissues of wild-type and dystrophin-deficient mice.
    Shibuya S; Hara H; Wakayama Y; Inoue M; Jimi T; Matsuzaki Y
    Tohoku J Exp Med; 2008 Aug; 215(4):313-9. PubMed ID: 18679005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal muscle function and water permeability in aquaporin-4 deficient mice.
    Yang B; Verbavatz JM; Song Y; Vetrivel L; Manley G; Kao WM; Ma T; Verkman AS
    Am J Physiol Cell Physiol; 2000 Jun; 278(6):C1108-15. PubMed ID: 10837338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myogenic Akt signaling attenuates muscular degeneration, promotes myofiber regeneration and improves muscle function in dystrophin-deficient mdx mice.
    Kim MH; Kay DI; Rudra RT; Chen BM; Hsu N; Izumiya Y; Martinez L; Spencer MJ; Walsh K; Grinnell AD; Crosbie RH
    Hum Mol Genet; 2011 Apr; 20(7):1324-38. PubMed ID: 21245083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of multiple AQP4 pools in the plasma membrane and their association with the dystrophin complex.
    Nicchia GP; Cogotzi L; Rossi A; Basco D; Brancaccio A; Svelto M; Frigeri A
    J Neurochem; 2008 Jun; 105(6):2156-65. PubMed ID: 18284610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.